Fang-Ling Zhao

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population

Jie Yang, D. Dai, Quan Zhou, 2022, Frontiers in Pharmacology.

Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo

Ji-hua Shi, D. Dai, Shuang-hu Wang, 2022, Drug design, development and therapy.

Naringenin has an inhibitory effect on rivaroxaban in rats both in vitro and in vivo

Jiefu Yang, D. Dai, Quan Zhou, 2021, Pharmacology Research & Perspectives.

Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo

Shuanghu Wang, D. Dai, Peiwu Geng, 2022, Frontiers in Pharmacology.

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo

D. Dai, Shuang-hu Wang, P. Geng, 2023, Pharmaceutical biology.

Non-destructive discrimination of the variety of sweet maize seeds based on hyperspectral image coupled with wavelength selection algorithm

Dong Liang, Quan Zhou, Wenqian Huang, 2020 .

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Lili Zou, D. Dai, Jiefu Yang, 2023, Frontiers in Endocrinology.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

D. Dai, Shuang-hu Wang, P. Geng, 2023, Frontiers in Pharmacology.